BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3683923)

  • 1. [Biomarkers in the control of the treatment of gastrointestinal carcinomas].
    Lorenzi M; Inaudi P; Caldarone R; Garzi A; Lorenzini L
    Minerva Chir; 1987 Oct; 42(20):1621-4. PubMed ID: 3683923
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tumor markers in the diagnosis of solid tumors].
    Koch OM
    Internist (Berl); 1992 Aug; 33(8):W79-86. PubMed ID: 1526714
    [No Abstract]   [Full Text] [Related]  

  • 3. [Curative interventions for recurrence of gastrointestinal carcinomas--incidence and prognosis].
    Hohenberger W; Altendorf-Hofmann A; Haas C
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():218-21. PubMed ID: 9101836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The "false positive" tumor marker in malignant testicular tumor].
    Bussar-Maatz R; Weissbach L; Dahlmann N; Mann K
    Urologe A; 1993 May; 32(3):177-82. PubMed ID: 8511831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dukes C2 colon cancer: what is appropriate follow-up?
    Semin Oncol; 1995 Jun; 22(3):xix; discussion xix-xx passim. PubMed ID: 7777864
    [No Abstract]   [Full Text] [Related]  

  • 6. False elevation of serum CA 15-3 levels in patients under follow-up for breast cancer.
    Aguiar-Bujanda D; Bohn-Sarmiento U; Aguiar-Morales J
    Breast J; 2004; 10(4):375-6. PubMed ID: 15239804
    [No Abstract]   [Full Text] [Related]  

  • 7. Follow-up of patients with gastrointestinal cancer by tumor marker determination.
    Lukinac L; Bolanca A; Nöthig-Hus D; Kusić Z
    Acta Med Croatica; 1997; 51(2):73-7. PubMed ID: 9204590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reresection for gastric carcinoma.
    Scheinin TM; Inberg MV; Linna MI
    Acta Chir Scand; 1968; 134(8):660-6. PubMed ID: 5713449
    [No Abstract]   [Full Text] [Related]  

  • 9. Increased levels of tumor markers in the follow-up of 400 patients with breast cancer without recurrence or metastasis: interpretation of false-positive results.
    Zervoudis S; Peitsidis P; Iatrakis G; Panourgias E; Koureas A; Navrozoglou I; Dubois JB
    J BUON; 2007; 12(4):487-92. PubMed ID: 18067207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma.
    Aoyagi Y; Oguro M; Yanagi M; Mita Y; Suda T; Suzuki Y; Hata K; Ichii K; Asakura H
    Cancer; 1996 May; 77(9):1781-6. PubMed ID: 8646674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
    Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
    Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The surveillance of gastrointestinal neoplasms after curative surgery].
    Mansikka A; Alhava E
    Duodecim; 2002; 118(8):789-95. PubMed ID: 12238193
    [No Abstract]   [Full Text] [Related]  

  • 13. [Follow-up of the CEA in gastrointestinal neoplasms after surgical intervention].
    Piantino P; Garrone C; Cattaneo U; Bonardi O; Toppino M; Pecchio F
    Minerva Dietol Gastroenterol; 1981; 27(4):541-5. PubMed ID: 7335225
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum p53 antibody as tumor marker for follow-up of colorectal cancer after curative resection.
    Tang R; Yeh CY; Wang JY; Changchien CR; Chen JS; Hsieh LL
    Ann Surg Oncol; 2009 Sep; 16(9):2516-23. PubMed ID: 19565285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of serum zinc, copper, ceruloplasmin levels in patients with gastrointestinal tract cancers.
    Boz A; Evliyaoğlu O; Yildirim M; Erkan N; Karaca B
    Turk J Gastroenterol; 2005 Jun; 16(2):81-4. PubMed ID: 16252197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of blood assay of tumor markers for detecting recurrence of colorectal cancer].
    Pélissier E; Bosset JF; Meneveau N
    Bull Cancer; 1994 Dec; 81(12):1050-6. PubMed ID: 7742592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tumor markers--how they should be applied].
    Stieber P; Heinemann V; Schalhorn A
    MMW Fortschr Med; 2005 May; 147(20):35, 37-9. PubMed ID: 15957858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Search for tumor cells in the venous blood in relation to postoperative care of cancer patients].
    Peckholz I; Melchert R
    Zentralbl Chir; 1966 Sep; 91(36):1313-7. PubMed ID: 5995396
    [No Abstract]   [Full Text] [Related]  

  • 19. [After-care of gastrointestinal malignancies--an evaluation of costs and benefits].
    Zieren HU; Müller JM
    Zentralbl Chir; 1996; 121(3):167-76. PubMed ID: 8867342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Important matters to identify robust markers for metastasis and recurrence in solid cancer.
    Mimori K; Iwatsuki M; Yokobori T; Mori M
    Ann Surg Oncol; 2009 Apr; 16(4):1070-1. PubMed ID: 19169757
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.